Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Nov 21 1997
WASHINGTON, D.C. (November 21, 1997) _ Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement...
Nov 10 1997
(WASHINGTON, DC, November 10, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
Nov 7 1997
(WASHINGTON, DC, October 7, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the House...
Jul 24 1997
(WASHINGTON, DC)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement in response to the...
Jul 22 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has been honored by the Public Relations Society of America (PRSA)/Richmond, VA chapter, for...
Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...
Jun 5 1997
WASHINGTON, D.C.-----Eleven international biotechnology organizations have endorsed the Biotechnology Industry Organization's (BIO) policy statement...
May 13 1997
WASHINGTON, D.C.,..Carl Feldbaum, president of the Biotechnology Industry Organization (BIO) will be a key speaker at a Texas panel that will discuss...